אודנטרון

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE

MAH:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

ATC_code:

A04AA01

pharmaceutical_form:

תמיסה להזרקה

composition:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2 MG/ML

administration_route:

תוך-ורידי, תוך-שרירי

prescription_type:

מרשם נדרש

manufactured_by:

KLEVA S.A., GREECE

therapeutic_group:

ONDANSETRON

therapeutic_area:

ONDANSETRON

therapeutic_indication:

Adults: Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV).Paediatric Population: Odantron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ?6 months, and for the prevention and treatment of PONV in children aged ?2 years.

authorization_date:

2018-07-31